Daré Bioscience, Inc. (DARE)
Develops medications for women's reproductive health, contraception, and sexual wellness.
$1.18-0.11%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-51.2%
The outlook
DARE is trading near the lower end of its 52-week range and below both its 50- and 200-day averages, reflecting weak near-term momentum. Analyst coverage is sparse, but the average price target sits significantly above the current price. The overall sentiment leans bearish based on current technicals.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +719% vs current price
Analyst price target
~12-month · 3 analysts$9.67average target+718.5% vs now
Now $1.18
Low $8.00High $12.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$17.7M
52-wk high
$3.78
52-wk low
$1.16
50-day avg
$2.02
200-day avg
$1.96
Trailing P/E
—